Is transesophageal echocardiography necessary before D.C. cardioversion in patients with a normal transthoracic echocardiogram?

Echocardiography

Volumn 24, Issue 4, 2007, Pages 397-400

  Sharifi, Mohsen ^a,b   Parhizgar, Alireza ^a   Gupta, Punam ^a   Mehdipour, Mahshid ^a   Emrani, Farnaz ^a   Baldwin, David ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Cardiovascular Associates of Mesa   (United States)

Author keywords

Atrial fibrillation; Cardioversion; Transesophageal echocardiography

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; OBSERVER VARIATION; RESEARCH DESIGN; RETROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME;

EID: 33947397607     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00400.x     Document Type: Article

References (10)

1. Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. J Am Coll Cardiol 2001;38:1231-1265.
2. Albers GW, Dalen JE, Laupacis A, et al: Antithrombotic therapy in atrial fibrillation. Chest 2001;119(1 suppl):194S-206S.
3. Thamilarasan M, Klein AL: Transesophageal echocardiography (TEE) in atrial fibrillation. Cardiol Clin 2000;18:819-831.
4. Manning WJ, Silverman DI, Gordon SP, et al: Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750-755.
5. Fatkin D, Kuchar DL, Thorburn CW, et al: Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-316.
6. Klein AL, Grimm RA, Black IW, et al: Cost effectiveness of TEE-guided cardioversion with anticoagulation compared to conventional therapy in patients with atrial fibrillation [abstract]. J Am Coll Cardiol 1994;23:128A.
7. Klein AL, Murray RD, Grimm RA: Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001;37:691-704.
8. Seidl K, Senges J: Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. Card Electrophysiol Rev 2003;7:392-396.
9. Seidl K, Rameken M, Drogemuller A, et al: Embolic events in patients with atrial fibrillation and effective anticoagulation: Value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 2002;39:1436-1442.
10. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: A report from The American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.